This compound is an N-protected derivative of L-glutamic acid, featuring a fluorenylmethoxycarbonyl (Fmoc) group and a tert-butyl ester. It is primarily used as a building block in solid-phase peptide synthesis.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 84793-07-7
(S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(tert-butoxy)-4-oxobutanoic acid
Fmoc-protected aspartic acid derivative
(S)-4-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-5-amino-5-oxopentanoic acid
Fmoc-protected amino acid derivative
4-(Dimethylamino)-2-butenoic acid hydrochloride
Pharmaceutical intermediate for API synthesis
N-(3-Cyano-7-ethoxy-4-hydroxyquinolin-6-yl)acetamide
pharmaceutical intermediate
N-(4-CHLORO-3-CYANO-7-ETHOXY-6-QUINOLINYL)ACETAMIDE
Pharmaceutical intermediate
4-{[3-(4-acetylpiperazine-1-carbonyl)-4-fluorophenyl]methyl}-1,2-dihydrophthalazin-1-one
Pharmaceutical intermediate
(4R)-5-(tert-butoxy)-4-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-5-oxopentanoic acid
Fmoc-protected amino acid derivative
(4S)-4-(9H-fluoren-9-ylmethoxycarbonylamino)-5-[(2-methylpropan-2-yl)oxy]-5-oxopentanoic acid
GOPWHXPXSPIIQZ-FQEVSTJZSA-N
CC(C)(C)OC(=O)[C@H](CCC(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13